Clinical Trial: Intelligent Prediction of Postoperative Recurrence Risk for Triple-Negative Breast Cancer (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Intelligent Prediction of Postoperative Recurrence Risk for Triple-Negative Breast Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129817

Registration Time: 2026/08/10

Type: Diagnostic test

Primary Sponsor: PEKING UNIVERSITY SHENZHEN HOSPITAL

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337558

Published by HT Digital Content Services with permission from Health Daily Digest....